IMMIX BIOPHARMA INC's ticker is and the CUSIP is 45258H106. A total of 32 filers reported holding IMMIX BIOPHARMA INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24 | – | 11,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 25,000 | $58 | 0.07% |
| Moss Adams Wealth Advisors LLC | 20,000 | $45,800 | 0.02% |
| Murchinson Ltd. | 67,200 | $153,888 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 33,600 | $76,944 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 12,597 | $28,847 | 0.00% |
| InterOcean Capital Group, LLC | 15,900 | $36,411 | 0.00% |
| UBS Group AG | 4,687 | $10,733 | 0.00% |
| OSAIC HOLDINGS, INC. | 350 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 76,537 | $175 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,356 | $5 | 0.00% |